LOHOCLA RESEARCH CORPORATION
Evanston, IL · Biotech · Private
Nezavist, a small-molecule therapeutic that acts as a positive allosteric modulator of GABA-A receptors via the enteric nervous system to reduce alcohol consumption in alcohol use disorder
- Grants
- $5.1M
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 14
- 6 granted · 8 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Nezavist a Novel Molecule for Treatment of Alcohol Use Disorder | $1,710,532 | |
| Federal grant | Department of Health and Human Services · Phase II · Nezavist a Novel Molecule for Treatment of Alcohol Use Disorder | $1,710,386 | |
| Federal grant | Department of Health and Human Services · Phase II · Nezavist a Novel Molecule for Treatment of Alcohol Use Disorder | $1,707,595 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1151 | Adaptive Phage Therapeutics, Inc. | — | $45M |
| 1152 | SERION, INC. | — | — |
| 1153 | THERASOURCE, LLC | — | — |
| 1154 | LOHOCLA RESEARCH CORPORATION | — | — |
| 1155 | ENSIGN PHARMACEUTICAL, INC. | — | — |
| 1156 | ALLIANCE DISCOVERY, INC. | — | — |
| 1157 | PALENA THERAPEUTICS, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Process For Preparing Diphenylureido-dihalokynurenic Acids And Tosylate Addition Salts Thereofgranted
- Multifunctional Aminoquinoline Therapeutic Agentsgranted
- Process For Preparing 1,4-DIHYDRO-4-OXOQUINOLINE-2-CARBOXYLATES And 4-AMINOQUINOLINE Compounds Therefromgranted
- Multifuncaional Aminoquinoline Therapeutic Agentgranted
- Analgesic Compositionsgranted
- Multifunctional Aminoquinoline Therapeutic Agentsgranted
- Diagnostic Tests Of Substance Use Disordersapplication
- Compounds And Methods For Treating Neuroinflammation And Neuropathologiesapplication
- Method For Treating Chronic Painapplication
- Compounds And Methods For Treating Neuroinflammation And Neuropathologiesapplication
- Process For Preparing 1,4-DIHYDRO-4-OXOQUINOLINE-2-CARBOXYLATES And 4-AMINOQUINOLINE Compounds Therefromapplication
- Analgesic Compositionsapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.